Describe the typical clinical features of common respiratory conditions Flashcards

1
Q

What is COPD?

A

A lung disease caused by inflammation of the small airways. Includes chronic bronchitis (characterized by productive cough ≥ 3 months in 2 consecutive years) and emphysema (dilation of the air spaces distal to the terminal bronchioles). Most cases of COPD (~ 90%) are caused by smoking.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the definition of emphysema?

A

Abnormal, permanent dilation of the air spaces distal to the terminal bronchioles leading to hyperinflation, hypoxia, and dyspnea. Caused by destruction of the alveolar walls and capillaries required for gas exchange. Etiological factors include smoking, air pollution, and inhalation of chemical fumes and dust. Emphysema is a key component of COPD. Emphysema commonly leads to the formation of bulla.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the definition of bronchitis?

A

A lower respiratory tract infection that causes inflammation of the bronchi. Most frequently caused by a viral infection. Typically manifests with a self-limited cough.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What is the definition of bronchiectasis?

A

An irreversible and abnormal dilation of the bronchial tree. Typically caused by chronic pulmonary infections, obstructive pulmonary diseases (e.g., COPD), or disorders of secretion clearance and mucous plugging (e.g., cystic fibrosis). Typically presents with chronic cough productive of copious, mucopurulent sputum.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are some of the signs of chronic bronchitis?

A

Elevated haemoglobin Polycythaemia Peripheral oedema Rhonchi and wheezing Overweight and cyanotic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the first line therapy for COPD?

A
  1. SABA/SAMA
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the second line therapy for patients with COPD who do not show asthmatic features?

A
  1. Offer a LABA+LAMA (Fluticasone + Tiotropium)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the third line therapy for patients with COPD who do not show asthmatic features?

A
  • add an ICS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the second line therapy for patients with COPD who do show asthmatic features?

A
  1. LABA + ICS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the third line therapy for patients with COPD who do show asthmatic features?

A
  • LABA + LAMA + ICS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What 5 therapies should be commenced in an acute exacerbation of COPD?

A
  1. Antibiotics
  2. Steroids
  3. Nebulised salbutamol
  4. Ipratropium bromide (SAMA)
  5. Oxygen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How can PFTs be used to make a diagnosis of COPD and stage it?

A

In pulmonary function testing, a post-bronchodilator FEV1/FVC ratio of <0.70 is commonly considered diagnostic for COPD. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) system categorises airflow limitation into stages. In patients with FEV1/FVC <0.70: GOLD 1 - mild: FEV1≥ 80% predicted GOLD 2 - moderate: 50% ≤ FEV1 < 80% predicted GOLD 3 - severe: 30% ≤ FEV1 < 50% predicted GOLD 4 - very severe: FEV1 <30% predicted.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What does LTOT stand for?

A

Long term oxygen therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are the criteria for receiving LTOT?

A

PaO2 <7.3kPa or 55mmHg (Between 55-65mmHg or 7.3-8kPa if the patient aslo has pulmonary hypertension, peripheral oedema, erythrocytosis) SaO2 <88%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is Cor pulmonale?

A

Altered structure (hypertrophy, dilation) or impaired functioning of the right ventricle caused by a primary disorder of the respiratory system (e.g., COPD, cystic fibrosis, interstitial lung disease, pulmonary embolism). The primary respiratory disorder causes acute/chronic pulmonary hypertension, which in turn causes acute/chronic right heart failure.

17
Q

What is the first line therapy for chronic asthma?

A
  • SABA inhaler
18
Q

What is the second line therapy for chronic asthma?

A
  1. SABA
  2. Low dose ICS
19
Q

What is the third line therapy for chronic asthma?

A
  1. SABA
  2. ICS
  3. LABA
20
Q

What is the FOURTH line therapy for chronic asthma?

A
  1. SABA
  2. ICS
  3. LABA
  4. LTRA
21
Q

What is a MART inhaler?

A

MART inhalers include a steroid preventer medicine and a certain type of long-acting bronchodilator medicine which can also be used as your emergency reliever.

22
Q

What is the first line medical therapy for pleural abscess?

A

Antibiotics

23
Q

What si the management of empyema?

A

Antibiotics

24
Q

What is the intervention for pneumothorax?

A

Thoracocentesis with 14 gauge needle in 2nd ICS MCL

25
Q

What are the indications for thoracocentesis in pneumothorax?

A
  1. tension
  2. breathlessness
  3. >2cm
26
Q

Give lights criteria for diagnosing a pleural effusion as exudative or transudtaive

A

The fluid is considered an exudate if any of the following are found:

  • Ratio of pleural fluid to serum protein > 0.5
  • Ratio of pleural fluid to serum LDH > 0.6
  • Pleural fluid LDH > two-thirds of the upper limits of normal serum value
27
Q

What is the maximum amount of fluid that should be removed from a pleural effusion?

A

1L is the maximum amount of fluid that should be removed, or re-perfusion pulmonary oedema may occur (sudden expansion of the lung stimulates stretch receptors, blood vessels then release vasoactive factors into the lung parenchyma)

28
Q

Where should a chest drain for a pleural effusion be placed?

A
  • 5th ICS MAL
29
Q

What is the management of a haemodynamically unstable patient with a PE?

A
  1. Start unfractionated heparin (UFH) in haemodynamically unstable patients prior to thrombolysis.
  2. alteplase thrombolysis
30
Q

What is the management of a haemodynamically unstable patient with a PE with an absolute contraindication to thrombolysis or anticoagulation?

A
  • vasoactive drug (dobutamine or noradrenaline)
31
Q

What is the STAR approach to quitting smoking?

A

S = Set a quit date (based on the patient’s willingness, motivation and agreement, usually within 2-4 weeks, abrupt quitting more effective than gradual)

T = Tell family and friends (encourage to create a strong support system)

A = Anticipate challenges/obstacles patient will face and how to overcome them

R = Remove all tobacco products, recommend counselling programs and pharmacological therapies as indicated

32
Q

What are the 3 pharmacological agents which can help with smoking cessation?

A
  1. NRT
  2. Bupropion (bupropion acts via dual inhibition of norepinephrine and dopamine reuptake)
  3. Varenicline (Nicotine receptor partial agonist)